1. Home
  2. HSBC vs LLY Comparison

HSBC vs LLY Comparison

Compare HSBC & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HSBC Holdings plc.

HSBC

HSBC Holdings plc.

N/A

Current Price

$89.38

Market Cap

336.4B

Sector

Finance

ML Signal

N/A

Logo Eli Lilly and Company

LLY

Eli Lilly and Company

N/A

Current Price

$1,445.87

Market Cap

1.3T

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HSBC
LLY
Founded
1865
1876
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
336.4B
1.3T
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
HSBC
LLY
Price
$89.38
$1,445.87
Analyst Decision
Buy
Buy
Analyst Count
3
31
Target Price
$103.02
★ $1,460.30
AVG Volume (30 Days)
1.8M
★ 2.4M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
★ 4.13%
0.48%
EPS Growth
N/A
★ 95.99
EPS
N/A
★ 23.42
Revenue
N/A
★ $65,179,000,000.00
Revenue This Year
$6.03
$40.64
Revenue Next Year
$5.29
$16.16
P/E Ratio
$94.79
★ $61.46
Revenue Growth
N/A
★ 44.70
52 Week Low
$67.56
$850.51
52 Week High
$107.92
$1,453.00

Technical Indicators

Market Signals
Indicator
HSBC
LLY
Relative Strength Index (RSI) 44.96 71.37
Support Level $88.26 $1,103.24
Resistance Level $92.06 N/A
Average True Range (ATR) 1.44 43.39
MACD 0.66 4.92
Stochastic Oscillator 64.62 92.04

Price Performance

Historical Comparison
HSBC
LLY

About HSBC HSBC Holdings plc.

Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and over 40 million customers worldwide. It operates in more than 50 countries with over 200,000 full-time staff. Hong Kong and the United Kingdom are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.

About LLY Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Share on Social Networks: